REZOLUTE, INC. Other Current Liabilities
REZOLUTE, INC. (RZLT) had Other Current Liabilities of $1.07 million as of 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2023-02-10
- 2022-12-31: Other Liabilities, Current $1.07M.
- 2022-09-30: Other Liabilities, Current $1.08M.
- 2022-06-30: Other Liabilities, Current $979.00K.
- 2022-03-31: Other Liabilities, Current $764.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2022-12-31 | $1.07M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $1.08M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $979.00K 10-Q · filed 2023-02-10 | |
| 2022-03-31 | $764.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $477.00K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $679.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $349.00K 10-K · filed 2022-09-15 | |
| 2021-03-31 | $469.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $543.00K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $300.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $180.00K 10-K · filed 2021-09-15 | |
| 2020-03-31 | $284.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $641.00K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $159.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $526.00K 10-K · filed 2020-10-13 | $28.00K 10-K · filed 2019-09-10 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $132.92K 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $114.00K 10-K · filed 2019-09-10 | $114.00K 10-K · filed 2018-10-15 |
| 2018-03-31 | $121.70K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $116.23K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $110.77K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $105.30K 10-K · filed 2018-10-15 | |
| 2017-03-31 | $119.27K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $125.21K 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $122.45K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $119.69K 10-K · filed 2017-09-22 | |
| 2016-03-31 | $116.95K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $114.27K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $101.35K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $98.67K 10-K · filed 2016-09-28 | |
| 2015-03-31 | $96.02K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $78.02K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $15.98K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $0.00 10-K · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |